We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Protocols and procedures for testing the value for cultivation or use (VCU) of agricultural crops.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Apply for a higher education course, track your application and accept or reject your offers.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Use a separate statement of objection form for each Japanese GI product name you object to.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines.
Pharmacovigilance system requirements
Guidance for manufacturers and distributors of premixtures and feedingstuffs containing veterinary medicines or specified feed additives.
This document explains: how patients are tested and treated, and steps in place to prevent its spread.
Guidance for the veterinary pharmaceutical industry on the production and submission of the Summary of Product Characteristics (SPCs) and product literature mock-ups.
Check how much your visa application costs in the country you’re in
Guidance to help organisations choose a monitoring approach for stack emissions to air that meets Environment Agency and MCERTS requirements (formerly part of M2).
Actions that trial sponsors should consider to build resilience into clinical trial design
Information about the EU Regulations and their implementation in Northern Ireland
An overview of the process including submitting or fast tracking an application, naming your medicine and paying fees.
Helping public health practitioners conducting evaluations on how to plan them.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Protocols and procedures for testing the distinctiveness, uniformity and stability (DUS) of certain agricultural and vegetable plants.
When tests to detect COVID-19 are commonly used (use cases) and what to consider when deciding which type of test to employ.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.